These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6098391)

  • 1. Serotonin (5HT) and its antagonists: involvement in the cardiovascular system.
    Marwood JF; Stokes GS
    Clin Exp Pharmacol Physiol; 1984; 11(5):439-55. PubMed ID: 6098391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypotensive activity of serotonin antagonists; correlation with alpha 1-adrenoceptor and serotonin receptor blockade.
    Kalkman HO; Harms YM; van Gelderen EM; Batink HD; Timmermans PB; van Zwieten PA
    Life Sci; 1983 Mar; 32(13):1499-505. PubMed ID: 6300582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that blood pressure reduction by serotonin antagonists is related to alpha receptor blockade in spontaneously hypertensive rats.
    Cohen ML; Fuller RW; Kurz KD
    Hypertension; 1983; 5(5):676-81. PubMed ID: 6311738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of bunitrolol on adrenergic and serotonergic receptors.
    Tsuchihashi H; Aono J; Nagatomo T; Kawada T; Ohta H; Imai S
    Jpn J Pharmacol; 1987 Nov; 45(3):349-56. PubMed ID: 2893855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between ketanserin and LY 53857 on vascular and cardiac 5-HT2 and alpha 1-adrenergic receptors in the pithed rat.
    Dabiré H; Chaouche-Teyara K; Cherqui C; Fournier B; Schmitt H
    Arch Int Pharmacodyn Ther; 1990; 306():57-64. PubMed ID: 1981667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat.
    Cohen ML; Fuller RW; Kurz KD
    J Pharmacol Exp Ther; 1983 Nov; 227(2):327-32. PubMed ID: 6313898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
    Cohen ML; Schenck KW; Kurz KD
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antagonists of 5-hydroxytryptamine on blood pressure in the anesthetised spontaneously hypertensive rat.
    Docherty JR; Warnock P
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S59-61. PubMed ID: 2446073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular smooth muscle serotonin and alpha-adrenoceptors.
    Marwood JF; Stokes GS
    Clin Exp Pharmacol Physiol; 1983; 10(3):265-7. PubMed ID: 6313264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of alpha 1-adrenoceptor antagonism of ketanserin on the nature of its 5-HT2 receptor antagonism.
    Marwood JF
    Clin Exp Pharmacol Physiol; 1994 Dec; 21(12):955-61. PubMed ID: 7736654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of potent and selective S2-serotonergic antagonists.
    Janssen PA
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S2-11. PubMed ID: 2412048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of a peripheral vascular but not an apparently central serotonergic response by xylamidine and BW 501C67.
    Fuller RW; Kurz KD; Mason NR; Cohen ML
    Eur J Pharmacol; 1986 Jun; 125(1):71-7. PubMed ID: 3732393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological profile of antihypertensive drugs with serotonin receptor and alpha-adrenoceptor activity.
    van Zwieten PA; Blauw GJ; van Brummelen P
    Drugs; 1990; 40 Suppl 4():1-8; discussion 28-30. PubMed ID: 1982649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for two distinct types of postsynaptic alpha-adrenoceptor in vascular smooth muscle in vivo.
    Drew GM; Whiting SB
    Br J Pharmacol; 1979 Oct; 67(2):207-15. PubMed ID: 40647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
    Ellwood AJ; Curtis MJ
    Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonergic and noradrenergic receptors in the rat brain: modulation by chronic exposure to ovarian hormones.
    Biegon A; Reches A; Snyder L; McEwen BS
    Life Sci; 1983 Apr; 32(17):2015-21. PubMed ID: 6188018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of alpha 1- and alpha 2-adrenoceptors in the vasoconstriction caused by ergometrine.
    Kalkman HO; Van Gelderen EM; Timmermans PB; Van Zwieten PA
    Eur J Pharmacol; 1982 Feb; 78(1):107-11. PubMed ID: 6281027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of a difference between ketanserin and ritanserin in central vs. peripheral serotonin receptor antagonism.
    Cohen ML; Bloomquist WL; Snoddy HD; Fuller RW
    Life Sci; 1989; 45(13):1185-9. PubMed ID: 2507847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can peripheral serotonergic blockade explain the hypotensive effect of ketanserin?
    Vanhoutte PM
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S105-9. PubMed ID: 2412025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central 5-hydroxytryptamine (5-HT) receptors in blood pressure regulation.
    Dabiré H
    Therapie; 1991; 46(6):421-9. PubMed ID: 1819150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.